Cipla Medpro South Africa (Pty) Ltd (“Cipla South Africa”) to acquire Actor Pharma (Pty) Ltd
Submitted by: Paul Miller, CEO, Cipla South Africa Save to Instapaper
Strengthens its over-the-counter product portfolio
South Africa, 5 September 2023 Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; hereafter referred to as "Cipla”) signed a binding term sheet with Actor Holdings (Pty) Limited to acquire 100% of the issued ordinary shares of Actor Pharma (Pty) Limited (“Actor”). This development underpins Cipla’s commitment and investment in its over the counter (OTC) business and supports its journey to be a leading healthcare player in South Africa. This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities and leverage cost synergies in the South African market.
Actor was founded in 2009 and has quickly grown to become the 5th largest, privately owned, OTC player in the South African private market. Actor specialises in OTC and generic medicine, where they have established strong consumer brands, and identified niche prescription markets in categories of Women’s health, Nasal, Cough & Cold and Baby & Child. In addition, Actor has an exciting and innovative pipeline and in its last financial year (FY23) delivered revenue of R234 million, on the back of strong double-digit growth.
Commenting on the acquisition, Umang Vohra, Global MD & CEO, Cipla Limited said, “This is in line with our strategy of strengthening our OTC and wellness portfolio. We believe this is an excellent opportunity to leverage our existing marketing capabilities, unlock future growth opportunities and optimise the performance of our pipeline”.
Paul Miller, CEO, Cipla South Africa said, “This is a unique opportunity that helps to build Cipla’s OTC portfolio, providing the business with a more balanced revenue contribution between the prescription and over-the-counter business and continue to provide additional quality medicines for consumers”.
Lynton Lomas, shareholder of Actor said, “We are delighted to transact with a company of Cipla’s stature. With the focussed approach of their commercial team, we are excited to see Actor grow from strength to strength in future”.
The transaction is expected to close in the next three to four months, subject to the negotiation and signing of the definitive transaction agreements (which are expected to be concluded imminently) as well as receiving regulatory approval from South Africa’s Competition Commission.
About Cipla South Africa
Cipla Medpro South Africa (Pty) Limited (‘Cipla South Africa’) is a wholly owned subsidiary of Cipla Limited, India (‘Cipla’) and 3rd largest pharmaceutical company in South Africa (and 2nd largest in the Rx sector). Through Cipla’s ethos of ‘Caring for Life’, Cipla South Africa produces world-class medicines at affordable prices for the public and private sectors, advancing healthcare for all South Africans.
For more information, visit www.cipla.co.za
Tribeca Public Relations is an award-winning, independent, Level 1 B-BBEE accredited PR agency based in Johannesburg.
Latest Press Articles
- From the Pitch to the Boardroom - What CFOs Can Learn from the Springboks
- How South Africa’s Top CFOs Manage Their Time
- Respublica Expands Its Reach - Addressing South Africa’s Student Housing Crisis with New Developments
- Nip allergies in the bud with new pollen count
- Wild Child Africa’s 2024 PONDO Trail Run - A Triumph of Adventure and Philanthropy
- Cathay Pacific returns to the world’s top five airlines in industry rankings and wins World’s Best Economy Class
- Are financial officers human?
- South Africa opens its doors to remote workers, and they come bearing economic gifts
- Guardians of tomorrow - Rethinking infant vaccination strategies
- Creating tomorrow’s content magic, today!
- Easy Ways To Manage Asthma Effectively This Winter
- Banish burnout in Cape Town this winter - Discover The Mother City’s favourite hidden gem, the Grotto Spa
- Five solo travel tips for exploring Hong Kong and beyond
- Cinema is coming home - Sony introduces its brightest and best sounding new BRAVIATM TVs to further enrich ultimate cinematic experience at home.
- Massive Bass. Ultimate Vibe – Sony Introduces ULT POWER SOUND, a New Series of Speakers and Headphones
The Pulse Updates
- New Report Reveals Msme Funding Realities In South Africa – And What Must Change (May 30, 2025)
- Opinion Piece: Incorporating Ai Into Workforce Planning (May 26, 2025)
- Bridging The Gap: Why Finance And Hr Must Collaborate For Business Success (May 19, 2025)
- Reclaiming Johannesburg’s Running Narrative Powered By The Streets. Refreshed By Pura. (May 16, 2025)
- Double Gold Triumph For Hansgrohe Innovations (May 16, 2025)